GlassScriptPhysician profile
Royce H Johnson
NPI 1336174655
$6,670.96
in general payments reported to CMS, 2019-2025
22 companies · $641 in 2025
The $641 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $4,235 · 2021: $158 · 2022: $373 · 2023: $360 · 2024: $496 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $4,130.00 | 2020 | |
| Shionogi INC | $626.78 | 2022-2025 | Fetroja |
| Astellas Pharma US INC | $556.28 | 2019-2025 | Cresemba |
| Abbvie INC. | $259.21 | 2022-2025 | |
| Viiv Healthcare Company | $154.98 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $142.50 | 2019-2024 | Zerbaxa, Recarbrio, Dificid |
| Organogenesis INC. | $104.01 | 2024 | Puraply Wound Matrix |
| Amgen INC. | $94.26 | 2024 | Actimmune |
| Emd Serono, INC. | $92.30 | 2020-2022 | |
| Allergan, INC. | $75.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $56.01 | 2019-2020 | |
| Pfizer INC. | $54.13 | 2019-2021 | |
| Insmed, INC. | $49.34 | 2019-2021 | |
| Dynavax Technologies Corporation | $49.30 | 2021-2023 | Heplisav-B |
| Janssen Biotech, INC. | $43.24 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $40.20 | 2022-2025 | Nuzyra |
| Epizyme, INC. | $33.92 | 2021-2022 | |
| Gilead Sciences, INC. | $29.07 | 2025 | |
| Bard Access Systems, INC. | $25.03 | 2019 | |
| Aimmune Therapeutics, INC. | $23.77 | 2025 | Vowst |
| Astrazeneca Pharmaceuticals LP | $16.90 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Royce Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.